WNK2 and neoplasm: Specifically, MIF can activate downstream signaling pathways such as MAPK (Mitogen-Activated Protein Kinase) and PI3K (Phosphoinositide 3-Kinase) by binding to CD74, promoting tumor cell proliferation, survival, and metastasis [113, 121].